1. Pratt CB, Horowitz, Meyer WH, et al. Phase II trial of ifosfamide in children with malignant solid tumors. Cancer Treat Rep 71:131–135, 1987.
2. Pratt CB, Douglass EC, Etcubanas E, et al. Clinical studies of ifosfamide/mesna at St. Jude Children’s Research Hospital, 1983–1988. Semin Oncol 16(Suppl 3): 51–55, 1989.
3. Goren MP, Wright RK, Pratt CB, et al. Potentiation of ifosfamide neurotoxicity, hematotoxicity and tubular nephrotoxicity by prior cisplatin therapy. Cancer Res 47:1457–1460, 1987.
4. Pratt CB, Goren MP, Meyer WH, et al. Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors. J Clin Oncol 8:1399–1401, 1990.
5. Pratt CB, Green AA, Horowitz ME, et al. Central nervous system toxicity following treatment of pediatric patients with ifosfamide/mesna. J Clin Oncol 4:1253–1261, 1986.